Peer Reviewed
Feature Article Paediatrics
Management of wheezy infants and preschool children
Abstract
This second article in a two-part series on wheeze in children focuses on the management of the more common causes in infants (aged under 1 year) and preschool children (aged 1 to 4 years) using the best available published evidence.
Key Points
- Most wheezy infants have acute bronchiolitis or transient early wheezing, neither of which generally warrants any specific therapy.
- Age has a significant bearing on the patient’s response to inhaled bronchodilators.
- Bronchodilators should not be used routinely for first-time wheezy infants with presumed acute viral bronchiolitis.
- Toddlers with wheezing associated respiratory infection (WARI) should be given a trial of inhaled bronchodilator as required.
- Infants and preschool children with persistent or frequently recurrent wheezing deserve a trial of long term preventive therapy with inhaled corticosteroids or a nonsteroidal preventer.
Get full access
Buy this article
Single article purchases are temporarily unavailable due to site maintenance.
If you would like to purchase an article during this time, please email us at [email protected] with the article details and we'll assist you directly. We'll also let you know when online purchasing is available again.
Thank you for your patience and understanding.
Already a subscriber? Login here.